Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

GLP-1 (7-36, amide) monoclonal antibody (8G9)

BPD-HYB-147-06-02 200 µg 664.00 USD
BPD-HYB-147-06-1 1 mg 2,978.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:Glucagon like peptide 1
Immunogen:Synthetic peptide corresponding to aa 7-36 amide of GLP-1 coupled to carrier.
UniProt ID:P01275
Species reactivity:Mammalian
Applications:ELISA, IHC
Recommended Dilutions/Conditions:Immunohistochemistry (1:500)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Purity Detail:Protein A/G-affinity purified.
Formulation:Liquid. In 0.01M phosphate buffer, pH 7.4, containing 0.5M sodium chloride and 15mM sodium azide.
Shipping:Blue Ice Not Frozen
Short Term Storage:+4°C
Scientific Background:Glucagon-like peptide 1(7-36)amide (GLP-1(7-36)amide) is the principal active form of GLP-1, the other being GLP-1(7-37). GLP-1 is a peptide hormone of the glucagon family, produced by the L cells of the intestinal mucosa from the same prohormone as glucagon. The active forms are potent stimulators of glucose-dependent insulin secretion. The sequence of GLP-1 is fully conserved in all mammalian species examined so far.
GLP-1 (7-36, amide) monoclonal antibody (5B10) image
Figure: Schematic glucagon-like peptide-1 (GLP-1) showing active, extended and metabolite forms along with select GLP-1 monoclonal antibodies.
Please mouse over
GLP-1 (7-36, amide) monoclonal antibody (5B10) image

Product Literature References

Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: a cross-sectional study: A. Hattori, et al.; BMJ Open 3, e003201 (2013), Application(s): IHC using human endomyocardial biopsy samples, Abstract; Full Text
Exocrine and Endocrine Modulation in Common Gastric Carcinoma: V. Canzonieri, et al.; Am. J. Clin. Pathol. 137, 712 (2012), Application(s): IHC using human primary stomach cancers, Abstract; Full Text
Expression of connective tissue growth factor and IGF1 in normal and neoplastic gastrointestinal neuroendocrine cells and their clinico-pathological significance: G.A. Kaltsas, et al.; Endocr. Relat. Cancer 18, 61 (2011), Application(s): IHC using human ileal mucosa, Abstract; Full Text

General Literature References

Immunoblockade of endogenous glucagon-like peptide-1 by monoclonal antibodies in conscious rats: effect on the insulin response to intragastric glucose: J. van Delft, et al.; Metabolism 48, 41 (1999), Abstract;
Monoclonal antibodies to glucagone-like peptide-1: M. Ghiglione, et al.; Digestion 54, 396 (1993),

Related Literature

Stem Cells
Stem Cells
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,